Legend Biotech Corporation (LEGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-465,946
-518,254
-446,349
-403,582
-266,373
Depreciation & amortisation
20,992
20,451
18,392
13,917
9,933
Stock-based compensation
59,314
47,680
34,338
20,158
4,760
Change in working capital
66,720
-71,344
181,029
161,834
-23,240
Accounts receivable
-2,280
-98,980
50,320
24,590
-45,000
Inventory
-15,003
-12,706
-13,893
51
-643
Accounts payable
9,678
-12,702
25,850
1,805
-4,348
Other working capital
-263,236
-415,998
-223,556
-243,869
-253,288
Other non-cash items
-52,258
-33,298
8,487
-286
83,601
Net cash provided by operating activities
-238,543
-393,276
-201,281
-198,465
-223,005
Cash flows from investing activities
Investments in property, plant and equipment
-24,693
-22,722
-22,275
-45,404
-30,283
Purchases of investments
-5,731,084
-4,863,149
-654,971
-377,956
-72,682
Sales/maturities of investments
5,524,498
5,076,534
614,859
230,081
98,288
Other investing activities
-87,752
-97,877
-14,705
-1,708
-19,493
Net cash used for investing activities
-319,394
92,786
-77,092
-194,983
-24,169
Cash flows from financing activities
Debt repayment
-3,699
-3,755
-2,596
-1,419
-2,602
Common stock issued
-
583,688
377,643
623,440
462,085
Other financing activities
-
-
-
-
-2,518
Net cash used provided by (used for) financing activities
792,765
791,490
377,976
626,663
618,879
Net change in cash
234,828
491,000
99,603
233,215
371,705
Cash at beginning of period
660,050
786,031
688,938
455,689
83,364
Cash at end of period
894,878
1,277,713
786,031
688,938
455,689
Free cash flow
Operating cash flow
-238,543
-393,276
-201,281
-198,465
-223,005
Capital expenditure
-24,693
-22,722
-22,275
-45,404
-30,283
Free cash flow
-263,236
-415,998
-223,556
-243,869
-253,288
© 2024 Yahoo. All rights reserved.